Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
9.86
-0.12 (-1.20%)
At close: Jun 27, 2025, 4:00 PM
9.97
+0.11 (1.12%)
After-hours: Jun 27, 2025, 7:45 PM EDT
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $2.56 billion as of June 27, 2025. Its market cap has decreased by -50.81% in one year.
Market Cap
2.56B
Enterprise Value
10.97B
1-Year Change
-50.81%
Ranking
Category
Stock Price
$9.86
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $2.56B, a decrease of -69.55%. That is a compound annual growth rate of -25.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 2.56B | -33.29% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 712.80B |
| Johnson & Johnson | 365.03B |
| AbbVie | 329.56B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.64B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 231.28B |
| AstraZeneca | 216.45B |